CURAXIS PHARMACEUTICAL CORP Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net
CURAXIS PHARMACEUTICAL CORP reported Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net of $79.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-14.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet · last filed 2012-05-14
- CURAXIS PHARMACEUTICAL CORP derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2012-03-31 was $79.00K, a 34.71% decline year-over-year.
- CURAXIS PHARMACEUTICAL CORP derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2011-12-31 was $189.00K, a 89.62% decline year-over-year.
- CURAXIS PHARMACEUTICAL CORP derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2011-09-30 was $733.00K, a 70.86% increase year-over-year.
- CURAXIS PHARMACEUTICAL CORP derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2011-06-30 was $243.00K.
- CURAXIS PHARMACEUTICAL CORP derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2011 was $1.29M, a 42.84% decline from fiscal 2010.
- CURAXIS PHARMACEUTICAL CORP derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2010 was $2.25M.
| Period end | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 3 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 6 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 9 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 12 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 41 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 127 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 130 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 133 month |
|---|---|---|---|---|---|---|---|---|
| 2012-03-31 | $79.00K 10-Q · filed 2012-05-14 | $268.00K derived: sum of 2 quarters · filed 2012-05-14 | $1.00M derived: sum of 3 quarters · filed 2012-05-14 | $1.24M derived: sum of 4 quarters · filed 2012-05-14 | $3.62M 10-Q · filed 2012-05-14 | |||
| 2011-12-31 | $189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $922.00K derived: sum of 2 quarters · filed 2012-03-29 | $1.17M derived: sum of 3 quarters · filed 2012-03-29 | $1.29M 10-K · filed 2012-03-29 | $3.54M 10-K · filed 2012-03-29 | |||
| 2011-09-30 | $733.00K 10-Q · filed 2011-11-10 | $976.00K derived: sum of 2 quarters · filed 2011-11-10 | $1.10M 10-Q · filed 2011-11-10 | $2.92M derived: sum of 4 quarters · filed 2012-05-14 | $3.35M 10-Q · filed 2011-11-10 | |||
| 2011-06-30 | $243.00K 10-Q · filed 2011-08-12 | $364.00K 10-Q · filed 2011-08-12 | $2.19M derived: sum of 3 quarters · filed 2012-05-14 | $2.61M derived: sum of 4 quarters · filed 2012-05-14 | $2.61M 10-Q · filed 2011-08-12 | |||
| 2011-03-31 | $121.00K 10-Q · filed 2012-05-14 | $1.94M derived: sum of 2 quarters · filed 2012-05-14 | $2.37M derived: sum of 3 quarters · filed 2012-05-14 | $2.37M derived: sum of 4 quarters · filed 2012-05-14 | ||||
| 2010-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $2.25M derived: sum of 2 quarters · filed 2012-03-29 | $2.25M derived: sum of 3 quarters · filed 2012-03-29 | $2.25M 10-K · filed 2012-03-29 | ||||
| 2010-09-30 | $429.00K 10-Q · filed 2011-11-10 | $429.00K derived: sum of 2 quarters · filed 2011-11-10 | $429.00K 10-Q · filed 2011-11-10 | |||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-12 | $0.00 10-Q · filed 2011-08-12 |